Brooks Laboratories Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Brooks Laboratories Limited cash flow conversion efficiency. Based on the latest financial reports, Brooks Laboratories Limited (BROOKS) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.19 Million ≈ $34.55K USD) by net assets (Rs1.16 Billion ≈ $12.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Brooks Laboratories Limited (2007–2025)

Cash flow conversion efficiency of Brooks Laboratories Limited from 2007 to 2025. This chart illustrates how Brooks Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Brooks Laboratories Limited stock quote for real-time trading data and today's change.

Brooks Laboratories Limited Cash Flow Conversion Ratio Explained

Brooks Laboratories Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Brooks Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brooks Laboratories Limited ranked by their cash flow conversion efficiency. Also see BROOKS market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Retractable Technologies Inc NYSE MKT:RVP	-0.008x
Personal Assets Trust plc LSE:PNL	-0.004x
Greenyield Bhd KLSE:0136	-0.008x
Shenzhen Shenbao Industrial Co Ltd SHE:200019	0.126x
S&K Polytec Co. Ltd KQ:091340	0.133x
EL. D. Mouzakis S.A AT:MOYZK	0.002x
Lancashire Holdings Ltd LSE:LRE	0.027x
Fun Yours Technology Co Ltd TWO:6482	0.018x

Annual Cash Flow Conversion Efficiency for Brooks Laboratories Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Brooks Laboratories Limited from 2007 to 2025. Review BROOKS cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs981.04 Million ≈ $10.61 Million	Rs17.62 Million ≈ $190.59K	0.018x	+112.17%
2024-03-31	Rs655.85 Million ≈ $7.09 Million	Rs-96.81 Million ≈ $-1.05 Million	-0.148x	+24.67%
2023-03-31	Rs739.53 Million ≈ $8.00 Million	Rs-144.91 Million ≈ $-1.57 Million	-0.196x	+29.70%
2022-03-31	Rs1.34 Billion ≈ $14.53 Million	Rs-374.41 Million ≈ $-4.05 Million	-0.279x	-594.81%
2021-03-31	Rs791.48 Million ≈ $8.56 Million	Rs44.59 Million ≈ $482.19K	0.056x	+159.05%
2020-03-31	Rs984.16 Million ≈ $10.64 Million	Rs-93.89 Million ≈ $-1.02 Million	-0.095x	-98.66%
2019-03-31	Rs1.05 Billion ≈ $11.37 Million	Rs-50.49 Million ≈ $-546.08K	-0.048x	+11.07%
2018-03-31	Rs1.14 Billion ≈ $12.38 Million	Rs-61.81 Million ≈ $-668.48K	-0.054x	-169.74%
2017-03-31	Rs1.24 Billion ≈ $13.41 Million	Rs96.01 Million ≈ $1.04 Million	0.077x	+16.39%
2016-03-31	Rs1.22 Billion ≈ $13.20 Million	Rs81.19 Million ≈ $878.02K	0.067x	+248.09%
2015-03-31	Rs1.11 Billion ≈ $12.05 Million	Rs21.29 Million ≈ $230.26K	0.019x	-81.66%
2014-03-31	Rs1.12 Billion ≈ $12.14 Million	Rs116.98 Million ≈ $1.27 Million	0.104x	+103.74%
2013-03-31	Rs1.05 Billion ≈ $11.40 Million	Rs53.90 Million ≈ $582.89K	0.051x	+361.70%
2012-03-31	Rs912.63 Million ≈ $9.87 Million	Rs-17.83 Million ≈ $-192.84K	-0.020x	-109.59%
2011-03-31	Rs194.27 Million ≈ $2.10 Million	Rs39.59 Million ≈ $428.16K	0.204x	-51.15%
2010-03-31	Rs136.42 Million ≈ $1.48 Million	Rs56.91 Million ≈ $615.45K	0.417x	+144.20%
2009-03-31	Rs85.37 Million ≈ $923.22K	Rs14.58 Million ≈ $157.71K	0.171x	-58.33%
2008-03-31	Rs49.11 Million ≈ $531.11K	Rs20.13 Million ≈ $217.73K	0.410x	+565.61%
2007-03-31	Rs17.58 Million ≈ $190.16K	Rs1.08 Million ≈ $11.71K	0.062x	--

About Brooks Laboratories Limited

NSE:BROOKS India Drug Manufacturers - Specialty & Generic

Market Cap

$20.86 Million

Rs1.93 Billion INR

Market Cap Rank

#24821 Global

#1373 in India

Share Price

Rs65.49

Change (1 day)

+1.44%

52-Week Range

Rs37.11 - Rs109.82

All Time High

Rs194.97